Holistic Remedies · Ingredient
Cordycepin
Formula: C10H13N5O3 · MW: 251.246 · Drug-likeness: 0.629
⚗️ Identity
Name
Cordycepin
Aliases / Synonyms
3'-Deoxyadenosine; 73-03-0; Cordycepine; 9-Cordyceposidoadenine; ADENOSINE, 3'-DEOXY-; 9-(beta-D-3'-Deoxyribofuranosyl)adenine; CCRIS 3233; UNII-GZ8VF4M2J8; EINECS 200-791-4
🧪 Chemistry
Molecular Weight
251.2460
LogP
-0.9508
Drug-likeness
0.629
H-Bond Acceptors
8
H-Bond Donors
3
Rotatable Bonds
2
🔗 External References
1
Clinical Trials
0
Meta-Analyses
20
PubMed References
Top Conditions Studied with Cordycepin
📋 Sample Trials
NCT00003005
Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia
Completed · Phase 1 · Leukemia
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
PMID 31182708
Cordycepin prevents radiation ulcer by inhibiting cell senescence via NRF2 and AMPK in rodents
Nat Commun · 2019
PMID 30766785
Cordycepin promotes browning of white adipose tissue through an AMP-activated protein kinase (AMPK)-dependent pathway
Acta Pharm Sin B · 2019
PMID 30717276
Cordycepin Suppresses Endothelial Cell Proliferation, Migration, Angiogenesis, and Tumor Growth by Regulating Focal Adhesion Kinase and p53
Cancers (Basel) · 2019
PMID 30081068
β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species
Cancer Lett · 2018
PMID 27063964
Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin
Cancer Lett · 2016
PMID 22537056
Blockade of adipocyte differentiation by cordycepin
Br J Pharmacol · 2012
🏥 Linked Health Topics 1 · matched via study conditions